ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Thyroid Cancer

Thyroid Cancer

A MALDI-TOF mass spectrometry (MassARRAY) mutation-detection panel shows promise for improving the presurgical diagnosis of thyroid cancers with fine needle aspirations, according to a pilot study.

As part of our coverage of the 2016 American Thyroid Association Annual Meeting we discuss active surveillance vs immediate lobectomy or thyroidectomy in papillary thyroid microcarcinoma.

In this interview on medullary thyroid carcinoma we discuss treatment strategies, prognostic biomarkers, surveillance following treatment, and more.

High-risk ultrasound findings strongly indicate that thyroid nodules are malignant, even when nodules are cytologically indeterminate following find needle aspiration.

Researchers have established estimates of occult nodal disease risk in patients after surgery for papillary thyroid cancer, using primary tumor stage and the number of lymph nodes examined.

Results of a phase II study indicated that the BRAF inhibitor vemurafenib was active in patients with BRAF V600E–mutated papillary thyroid cancer who were refractory to radioactive iodine.

Radioguided sentinel lymph node biopsy detected occult cervical lymph node metastases in about one-half of patients with thyroid nodules suspicious for papillary thyroid carcinoma, altering the management of their disease.

Pages

Subscribe to Thyroid Cancer on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.